https://covid19criticalcare.com/wp-content/uploads/2020/06/MATH_ReleaseProtocol_2020-6-16_FLCCC.pdf Protocol found here
Please notice one of Wisconsin’s own, Pierre Kory, M.D, medical director at the Trauma & Life Support Center and a faculty member in the Division of Allergy, Pulmonary and Critical Care Medicine in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, is a part of FLCCC (Front Line COVID-19 Critical Care Working Group).
If the MATH+ protocol works with near-100% effectiveness, a vaccine may not even be necessary. The MATH+ protocol gets its name from:
| Intravenous Methylprednisolone
High-dose intravenous Ascorbic acid Plus optional treatments Thiamine, zinc and vitamin D Full dose low molecular weight Heparin |
Kory’s testimony transcript reviews and summarizes the MATH+ protocol, and explains why the timing of the treatment is so important. As explained by Kory, there are two distinct yet overlapping phases of COVID-19 infection.
- Phase 1 is the viral replication phase. Typically, patients will only experience mild symptoms, if any, during this phase. At this time, it’s important to focus on antiviral therapies.
- In Phase 2, the hyperinflammatory immune response sets in, which can result in organ failures (lungs, brain, heart and kidneys). The MATH+ protocol is designed to treat this active phase, but it needs to be administered early enough.
